Omega Healthcare Investors, Inc. — 2016 Form 10-K Summary
Business context and reporting period
Annual report for the fiscal year ended December 31, 2016, filed February 24, 2017. Omega is a self-administered healthcare REIT focused primarily on skilled nursing facilities in the United States and United Kingdom. It owns, leases, finances, and provides loans secured by healthcare properties.
- Portfolio: 996 facilities in 42 states and the U.K., operated by 79 third-party operators.
- Facility mix: 809 skilled nursing facilities, 101 assisted living facilities, 16 specialty facilities, one medical office building, and 23 closed or held-for-sale facilities.
- Gross investments, net of impairments and loan reserves: approximately $8.9 billion.
- Omega owned approximately 96% of Omega OP at year-end; outside investors owned approximately 4%.
Financial performance and key metrics
| Metric | 2016 | 2015 | Change |
|---|---|---|---|
| Operating revenues | $900.8 million | $743.6 million | +21.1% |
| Income before other income and expense | $509.7 million | $411.3 million | +24.0% |
| Net income | $383.4 million | $233.3 million | +64.3% |
| Net income available to common stockholders | $366.4 million | $224.5 million | +63.2% |
| Basic EPS | $1.91 | $1.30 | +$0.61 |
| Diluted EPS | $1.90 | $1.29 | +$0.61 |
| NAREIT FFO | $660.1 million | $455.3 million | +45.0% |
| Cash flow from operating activities | $625.8 million | $463.9 million | +34.9% |
| Common dividends declared per share | $2.36 | $2.18 | +8.3% |
- Approximate operating margin was 56.6%; net margin was 42.5%; and NAREIT FFO margin was 73.3%.
- Rental income increased to $743.9 million from $606.0 million, primarily reflecting the full-year impact of the Aviv merger and Care Homes transaction and additional 2015–2016 investments.
- Direct financing lease income was $62.3 million, mortgage interest income was $69.8 million, and other investment income was $21.9 million.
- Operating expenses were $391.1 million, including $267.1 million of depreciation and amortization, $58.7 million of real estate impairment charges, and $9.8 million of provisions for uncollectible receivables.
- Interest expense was $164.1 million. Total debt at year-end was approximately $4.4 billion, representing approximately 50.9% of total capitalization.
Fourth-quarter information
The filing’s unaudited quarterly data reports fourth-quarter 2016 revenue of $234.5 million, net income of $129.9 million, net income available to common stockholders of $124.3 million, basic EPS of $0.63, diluted EPS of $0.63, and cash dividends paid of $0.61 per share.
Balance sheet, liquidity, and cash flow
| Balance-sheet item | December 31, 2016 | December 31, 2015 |
|---|---|---|
| Total assets | $8.95 billion | $7.99 billion |
| Total equity | $4.21 billion | $4.10 billion |
| Total debt, net | $4.37 billion | $3.54 billion |
| Cash and cash equivalents | $93.7 million | $5.4 million |
| Real estate investments, net | $6.33 billion | $5.72 billion |
- Operating activities generated $625.8 million of cash.
- Investing activities used $1.11 billion, principally for $959.7 million of real estate acquisitions, $271.6 million of other investments, $50.0 million for an unconsolidated joint venture, and capital improvements.
- Financing activities provided $576.3 million, including net long-term borrowings and proceeds from the dividend reinvestment plan, partially offset by $453.2 million of dividends paid.
- Year-end liquidity included $93.7 million of cash and a $1.25 billion senior unsecured revolving credit facility, of which $190 million was outstanding.
- Contractual debt payments totaled $4.42 billion, including $302.8 million due within one year. Contractual interest payments totaled $1.41 billion.
- The company stated that cash flows from operations, available credit capacity, and expected mortgage payoffs were adequate for operations, debt service, dividends, and planned investments over the following twelve months.
Material changes versus the prior comparable period
- Omega completed approximately $1.3 billion of new investments in 2016, including 70 acquired facilities, loans, capital expenditures, and a $50 million investment for an approximately 15% interest in an unconsolidated joint venture.
- The company issued $700 million of 4.375% senior notes due 2023, generating approximately $692 million of net proceeds. Proceeds were used partly to repay revolving borrowings and purchase a $180 million mortgage term loan.
- Debt increased by approximately $827 million from year-end 2015, primarily due to acquisition financing and the new senior notes. The company reported compliance with its debt covenants.
- Omega sold 38 facilities for approximately $169.6 million of net proceeds and recognized a $50.2 million gain, compared with seven facilities sold and a $6.4 million gain in 2015.
- Real estate impairment charges increased to $58.7 million from $17.7 million, primarily reflecting the exit from certain non-strategic facilities and operators, including properties acquired in the Aviv merger.
- Acquisition and merger-related costs declined to $9.6 million from $57.5 million because 2015 included substantial Aviv merger and Care Homes transaction costs.
- Operator coverage ratios modestly declined during 2016 due to higher labor costs, weaker quality mix, and pressure on lengths of stay, although management believed operators could withstand moderate reimbursement reductions.
Guidance, outlook, risks, contingencies, and unusual items
- No formal quantitative earnings or investment guidance is provided in the filing.
- Management described an increasingly difficult skilled-nursing environment, citing labor and liability cost inflation, evolving reimbursement models, and more aggressive regulation and enforcement.
- Government reimbursement risk is significant because operators depend heavily on Medicare and Medicaid. Rate reductions, payment audits, value-based purchasing, bundled payments, and changes to the Healthcare Reform Law could weaken operator cash flows and rent coverage.
- CMS issued a 2016 final rule imposing extensive new requirements on skilled nursing facilities, with additional implementation phases beginning in 2017 and 2019. CMS estimated average implementation costs of $62,900 in the first year and $55,000 annually thereafter.
- Operator bankruptcy, lease rejection, foreclosure delays, inability to re-lease properties, litigation, licensing failures, quality deficiencies, fraud-and-abuse investigations, and uninsured liabilities could reduce rental and mortgage collections.
- Interest-rate and refinancing risk remain material. Approximately $302.8 million of debt was scheduled to mature within one year, including $200 million of Tranche A-2 term loans and $100 million of Omega OP term loans, subject to extension options described in the filing.
- A 1% increase in interest rates was estimated to reduce the fair value of long-term borrowings by approximately $246 million.
- Foreign currency translation losses, primarily related to the U.K. portfolio, reduced other comprehensive income by $46.5 million in 2016.
- Omega recorded $8.7 million of reserves on mortgages and other investments at year-end, compared with $3.0 million in 2015.
- The filing discloses that approximately 6.56 million shares were issued under the dividend reinvestment and stock purchase plan from March 5 through December 31, 2016 under an expired registration statement. A new registration statement became effective January 4, 2017.
- Management and Ernst & Young reported effective disclosure controls and internal control over financial reporting. Ernst & Young issued unqualified audit opinions.
Most important facts for investors to verify
- Whether operator coverage ratios and rent collections stabilize or deteriorate as labor costs and reimbursement pressures continue.
- The refinancing plan and extension or repayment status for the $302.8 million of debt due within one year.
- The magnitude and recurrence of real estate impairments, uncollectible receivables, operator transitions, and asset sales.
- Actual available capacity under the revolving credit facility and compliance with leverage, coverage, and other debt covenants.
- Whether the $2.36 annual dividend remains covered by recurring cash flow and FFO after capital expenditures and debt service.
- Exposure to major operators and concentrations by state; five operators represented approximately 35% of the portfolio by investment, while Ohio, Florida, and Texas represented approximately 10%, 9%, and 9%, respectively.
- The effect of Medicare and Medicaid policy changes, CMS quality requirements, enforcement activity, and potential Healthcare Reform Law changes on operators and property values.
- The tax and registration implications of the 2016 dividend reinvestment plan share issuance described in the filing.